IJPMBS 2026 Vol.15(2): 16-19
doi: 10.18178/ijpmbs.15.2.16-19
doi: 10.18178/ijpmbs.15.2.16-19
The Application and Progress of Natural Bioactive Constituents in Liver Cancer
Wen Li
College of Pharmacy, Shanxi Medical University, Jinzhong City, Shanxi Province, China
Email: liwenlw1024@163.com
Email: liwenlw1024@163.com
Manuscript received March 31, 2026; accepted April 21, 2026; published May 9, 2026.
Abstract—Liver cancer has been plaguing the world with its high incidence and mortality rates. Existing targeted therapy, immunotherapy, and chemotherapy have shortcomings such as drug resistance, obvious adverse reactions, and limited efficacy, so there is an urgent need to develop new treatment strategies. Natural Bioactive Constituents (NCBs) have become a research hotspot in liver cancer due to their multi-target, multi-pathway, and low-toxicity characteristics. This article searched relevant databases and systematically reviewed the anti-liver cancer mechanisms of active ingredients in natural medicines, including cell cycle regulation, induction of apoptosis, and ferroptosis. At the same time, it explored the application value of the combined strategy of NCBs. It also summarizes the innovative applications of passive, active, and physicochemically targeted delivery systems in overcoming the physicochemical drawbacks of natural drugs and enhancing their bioavailability.
Keywords—natural bioactive constituents, liver cancer, treatment mechanism, delivery system, combination
Cite: Wen Li , "The Application and Progress of Natural Bioactive Constituents in Liver Cancer," International Journal of Pharma Medicine and Biological Sciences, Vol. 15, No. 2, pp. 16-19, 2026.
Copyright © 2026 by the authors. This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Cite: Wen Li , "The Application and Progress of Natural Bioactive Constituents in Liver Cancer," International Journal of Pharma Medicine and Biological Sciences, Vol. 15, No. 2, pp. 16-19, 2026.
Copyright © 2026 by the authors. This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
